Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$235,080
+$5,955 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,245
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICOLET BANKSHARES INC holds $53,996,275 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,329 | $15,987,203 | |
| 2 | JNJ |
Johnson & Johnson
|
47,859 | $12,154,749 | |
| 3 | ABBV |
AbbVie Inc.
|
42,391 | $10,667,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,130 | $3,614,705 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
50,571 | $2,913,900 | |
| 6 | PFE |
Pfizer Inc
|
109,634 | $2,639,986 | |
| 7 | GSK |
GSK plc
|
44,504 | $2,332,898 | |
| 8 | BIIB |
Biogen Inc.
|
6,476 | $1,399,203 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,080 | 1,500 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $229,125 | 1,500 | Shares | Other | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||